Development of Competitive ELISAs Suitable for Detection of Recombinant Human Growth Hormone in Illegal Nutritional Supplements
Status PubMed-not-MEDLINE Jazyk angličtina Země Spojené státy americké Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
40519661
PubMed Central
PMC12165756
DOI
10.1155/jamc/3021570
Knihovny.cz E-zdroje
- Klíčová slova
- black market, competitive ELISA, doping, growth hormone, nutritional supplements,
- Publikační typ
- časopisecké články MeSH
The use of human growth hormone (hGH) by athletes remains widespread despite being banned by the World Anti-Doping Agency (WADA). Current commercial ELISA kits for the determination of hGH are predominantly based on the sandwich format of this method, which allows the analysis of the whole hGH molecules, but not their fragments. The abuse of these fragments by athletes is the current trend in doping. Therefore, a competitive ELISA format is needed; however, only a limited number of kits on the market are based on this principle. Furthermore, these kits are designed to detect and quantify hGH only in blood plasma, serum or tissue cultures. When analysing a nutritional supplement containing hGH using one of these ELISA kits, a false negative result was observed. In the present work, two competitive ELISA methods for the detection of hGH in illegal nutritional supplements were developed. The development of the methods involved the selection of suitable immunoreagents and their combinations with subsequent optimisation of the conditions for their use. The methods were then characterised (with LOD 0.4 and 18.4 ng/mL, according to the primary antibody) and applied to analyse real nutritional supplements. In all 34 samples suspected of containing hGH, the hormone was detected using both ELISA methods and subsequently confirmed by LC-UV and LC-MS. Therefore, the newly developed ELISA methods could become a valuable tool for the police in identifying illegal preparations.
Zobrazit více v PubMed
Baumann G. P. Growth Hormone Doping in Sports: A Critical Review of Use and Detection Strategies. Endocrine Reviews . 2012;33(2):155–186. doi: 10.1210/er.2011-1035. PubMed DOI
Erotokritou-Mulligan I., Holt R. I., Sönksen P. H. Growth Hormone Doping: A Review. Open Access Journal of Sports Medicine . 2011;2:99–111. doi: 10.2147/OAJSM.S11626. PubMed DOI PMC
Duntas L. H., Popovic V. Hormones as Doping in Sports. Endocrine . 2013;43(2):303–313. doi: 10.1007/s12020-012-9794-9. PubMed DOI
Sieckmann T., Elmongy H., Ericsson M., Bhuiyan H., Lehtihet M., Ekström L. Longitudinal Studies of Putative Growth Hormone (GH) Biomarkers and Hematological and Steroidal Parameters in Relation to 2 Weeks Administration of Human Recombinant GH. Drug Testing and Analysis . 2020;12(6):711–719. doi: 10.1002/dta.2787. PubMed DOI
Holt R. I., Ho K. K. The Use and Abuse of Growth Hormone in Sports. Endocrine Reviews . 2019;40(4):1163–1185. doi: 10.1210/er.2018-00265. PubMed DOI
Bidlingmaier M., Strasburger C. J. Growth Hormone. Handbook of Experimental Pharmacology . 2010;195:187–200. doi: 10.1007/978-3-540-79088-4_8. PubMed DOI
Velloso C. P. Regulation of Muscle Mass by Growth Hormone and IGF-I. British Journal of Pharmacology . 2008;154(3):557–568. doi: 10.1038/bjp.2008.153. PubMed DOI PMC
Saugy M., Robinson N., Saudan C., Baume N., Avois L., Mangin P. Human Growth Hormone Doping in Sport. British Journal of Sports Medicine . 2006;40(1):i35–i39. doi: 10.1136/bjsm.2006.027573. PubMed DOI PMC
Wahi A., Nagpal R., Verma S., Narula A., Kumar Tonk R., Kumar S. A Comprehensive Review on Current Analytical Approaches Used for the Control of Drug Abuse in Sports. Microchemical Journal . 2023;191:p. 108834. doi: 10.1016/j.microc.2023.108834. DOI
World Anti-Doping Agency. The World Anti-Doping Code International Standard Prohibited List 2025 . 2025. https://www.wada-ama.org/sites/default/files/2024-09/2025list_en_final_clean_12_september_2024.pdf .
Siebert D. M., Rao A. L. The Use and Abuse of Human Growth Hormone in Sports. Sport Health: A Multidisciplinary Approach . 2018;10(5):419–426. doi: 10.1177/1941738118782688. PubMed DOI PMC
De Palo E. F., De Filippis V., Gatti R., Spinella P. Growth Hormone Isoforms and Segments/Fragments: Molecular Structure and Laboratory Measurement. Clinica Chimica Acta . 2006;364(1-2):67–76. doi: 10.1016/j.cca.2005.06.009. PubMed DOI
Cox H. D., Smeal S. J., Hughes C. M., Cox J. E., Eichner D. Detection and In Vitro Metabolism of AOD9604. Drug Testing and Analysis . 2015;7(1):31–38. doi: 10.1002/dta.1715. PubMed DOI
Popii V., Baumann G. Laboratory Measurement of Growth Hormone. Clinica Chimica Acta . 2004;350(1-2):1–16. doi: 10.1016/j.cccn.2004.06.007. PubMed DOI
Moura J. F., DeLacerda L., Sandrini R., et al. ELISA for Determination of Human Growth Hormone: Recognition of Helix 4 Epitopes. BioMed Research International . 2004;2004(3):143–149. doi: 10.1155/S1110724304308090. PubMed DOI PMC
Marchand A., Roy D., Monsheimer S. A., Lewis J., Ericsson M. Development of a Microplate Duplex Immunoassay to Simplify Detection of Growth Hormone Doping: Proof of Concept. Drug Testing and Analysis . 2022;14(4):724–732. doi: 10.1002/dta.3197. PubMed DOI
Mellado M., Rodriguez-Frade J. M., Kremer L., Martinez-Alonso C. Characterization of Monoclonal Antibodies Specific for the Human Growth Hormone 22K and 20K Isoforms. Journal of Clinical Endocrinology & Metabolism . 1996;81(4):1613–1618. doi: 10.1210/jcem.81.4.8636376. PubMed DOI
Yuki Y., Kato K. A 22 kDa Human Growth Hormone Specific Enzyme-Linked Immunosorbent Assay. Biological and Pharmaceutical Bulletin . 1994;17(7):977–979. doi: 10.1248/bpb.17.977. PubMed DOI
Tsushima T., Katoh Y., Miyachi Y., et al. Serum Concentration of 20 K Human Growth Hormone (20 K hGH) Measured by a Specific Enzyme-Linked Immunosorbent Assay. Journal of Clinical Endocrinology & Metabolism . 1999;84(1):317–322. doi: 10.1210/jcem.84.1.5395. PubMed DOI
Wu Z., Bidlingmaier M., Friess S. C., et al. A New Nonisotopic, Highly Sensitive Assay for the Measurement of Human Placental Growth Hormone: Development and Clinical Implications. Journal of Clinical Endocrinology & Metabolism . 2003;88(2):804–811. doi: 10.1210/jc.2002-020787. PubMed DOI
Equey T., Pastor A., de la Torre Fornell R., et al. Application of the Athlete Biological Passport Approach to the Detection of Growth Hormone Doping. Journal of Clinical Endocrinology & Metabolism . 2022;107(3):649–659. doi: 10.1210/clinem/dgab799. PubMed DOI
Jing J., Yang S., Zhou X., et al. Detection of Doping With rhGH: Excretion Study With WADA-Approved Kits. Drug Testing and Analysis . 2011;3(11-12):784–790. doi: 10.1002/dta.359. PubMed DOI
Miller G. D., Husk J., Crouch A. K., Eichner D. Growth Hormone Isoform Testing in Capillary Dried Blood Spots: Results From Single and Multiple Dose Administration Studies and Large-Scale Field Collections. Drug Testing and Analysis . 2022;14(7):1255–1263. doi: 10.1002/dta.3248. PubMed DOI
Henninge J., Pepaj M., Hullstein I., Hemmersbach P. Identification of CJC-1295, a Growth-Hormone-Releasing Peptide, in an Unknown Pharmaceutical Preparation. Drug Testing and Analysis . 2010;2(11-12):647–650. doi: 10.1002/dta.233. PubMed DOI
Kohler M., Thomas A., Geyer H., Petrou M., Schänzer W., Thevis M. Confiscated Black Market Products and Nutritional Supplements With Non-Approved Ingredients Analyzed in the Cologne Doping Control Laboratory 2009. Drug Testing and Analysis . 2010;2(11-12):533–537. doi: 10.1002/dta.186. PubMed DOI
Krug O., Thomas A., Walpurgis K., et al. Identification of Black Market Products and Potential Doping Agents in Germany 2010–2013. European Journal of Clinical Pharmacology . 2014;70(11):1303–1311. doi: 10.1007/s00228-014-1743-5. PubMed DOI
Hullstein I. R., Malerod-Fjeld H., Dehnes Y., Hemmersbach P. Black Market Products Confiscated in Norway 2011-2014 Compared to Analytical Findings in Urine Samples. Drug Testing and Analysis . 2015;7(11–12):1025–1029. doi: 10.1002/dta.1900. PubMed DOI
McLean S. M., Desmond D. B., Salmon P. M. An Analysis of the Sports Performance Enhancing Substances Available on the Darknet. Performance Enhancement & Health . 2023;11(2):p. 100246. doi: 10.1016/j.peh.2023.100246. DOI
Kvillemo P., Strandberg A. K., Elgán T. H., Gripenberg J. Facilitators and Barriers in Preventing Doping Among Recreational Athletes: A Qualitative Interview Study Among Police Officers. Frontiers in Public Health . 2022;10:p. 1017801. doi: 10.3389/fpubh.2022.1017801. PubMed DOI PMC
Marty M. T., Baldwin A. J., Marklund E. G., Hochberg G. K. A., Benesch J. L. P., Robinson C. V. Bayesian Deconvolution of Mass and Ion Mobility Spectra: From Binary Interactions to Polydisperse Ensembles. Analytical Chemistry . 2015;87(8):4370–4376. doi: 10.1021/acs.analchem.5b00140. PubMed DOI PMC
Fellers R. T., Greer J. B., Bryan P. E., et al. ProSight Lite: Graphical Software to Analyze Top-Down Mass Spectrometry Data. Proteomics . 2014;15(7):1235–1238. doi: 10.1002/pmic.201400313. PubMed DOI PMC
Yuki Y., Kato K. A. A 22 kDa Human Growth Hormone Specific Enzyme-Linked Immunosorbent Assay. Biological and Pharmaceutical Bulletin . 1994;17(7):977–979. doi: 10.1248/bpb.17.977. PubMed DOI
Moura J. F., DeLacerda L., Sandrini R., et al. ELISA for Determination of Human Growth Hormone: Recognition of Helix 4 Epitopes. BioMed Research International . 2004;2004(3):143–149. doi: 10.1155/S1110724304308090. PubMed DOI PMC
Sleumer B., van Faassen M., Vos M. J., Bischoff R., Kema I. P., van de Merbel N. C. Selective Quantification of the 22-kDa Isoform of Human Growth Hormone 1 in Serum and Plasma by Immunocapture and LC–MS/MS. Analytical and Bioanalytical Chemistry . 2022;414(20):6187–6200. doi: 10.1007/s00216-022-04188-z. PubMed DOI PMC
Growth Hormone. High Sensitivity ELISA Kit MBS590029 . 2025. https://www.mybiosource.com/hgh-elisa-kits/growth-hormone/590029 .
Human Growth Hormone ELISA Kit EL10030 . 2025. https://elisa-kits.de/en/human-growth-hormone-hgh-626979.html .
Human Growth Hormone ELISA Kit (High Sensitivity) A33016 . 2025. https://www.antibodies.com/catalog/elisa-kits/human-growth-hormone-elisa-kit-high-sensitivity-a33016 .
Human GH/Growth Hormone (Sandwich ELISA) ELISA Kit-LS-F447 . 2025. https://www.lsbio.com/elisakits/human-gh-growth-hormone-sandwich-elisa-elisa-kit-ls-f447/447 .
Human Growth Hormone Quantikine ELISA Kit DGH00 . 2025. https://www.bio-techne.com/p/elisa-kits/human-growth-hormone-quantikine-elisa-kit_dgh00 .
Invitrogen Human Growth Hormone ELISA Kit . 2025. https://www.thermofisher.com/elisa/product/Human-Growth-Hormone-ELISA-Kit/EHGH1 .
Human GH ELISA Kit RAB0206 . 2025. https://www.sigmaaldrich.com/CZ/cs/product/sigma/rab0206 .
Human GH ELISA Kit ELH-GH-1 . 2025. https://www.raybiotech.com/human-gh-elisa-elh-gh .
Human Growth Hormone ELISA Kit (High Sensitivity) A581 . 2025. https://www.antibodies.com/catalog/elisa-kits/human-growth-hormone-elisa-kit-a581 .
Human Growth Hormone ELISA Kit EA100399 . 2025. https://www.origene.com/catalog/assay-kits/elisa-kits/ea100399-human-growth-hormone-elisa-kit .
Human Growth Hormone ELISA Kit Ab190811 . 2025. https://www.abcam.com/en-us/products/elisa-kits/human-growth-hormone-elisa-kit-ab190811 .
AuthentiKine™ Human Growth Hormone ELISA Kit . 2025. https://www.ptglab.com/products/AuthentiKine-Human-Growth-Hormone-ELISA-Kit-KE00221.htm .
Human GH/Growth Hormone (Competitive EIA) ELISA Kit-LS-F10631 . 2025. https://www.lsbio.com/elisakits/human-gh-growth-hormone-competitive-eia-elisa-kit-ls-f10631/10631 .
Human Growth Hormone ELISA Kit MBS284646 . 2025. https://www.mybiosource.com/gh-human-elisa-kits/growth-hormone/284646 .